Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
January 16th, 2013
25.4K views
A specific and rapid protocol to simultaneously investigate right heart function, lung inflammation, and the immune response is described as a learning tool. Video and figures describe physiology and microdissection techniques in an organized team-approach that is adaptable to be used for small to large sized studies.
Overview
This article presents a specific and rapid protocol designed to investigate right heart function, lung inflammation, and the immune response. It serves as a learning tool, with accompanying video and figures that illustrate physiology and microdissection techniques in a structured team approach suitable for various study sizes.
Key Study Components
Area of Science
- Cardiovascular physiology
- Immunology
- Respiratory health
Background
- Understanding right heart function is crucial for assessing cardiovascular health.
- Lung inflammation plays a significant role in respiratory diseases.
- The immune response is integral to both cardiovascular and pulmonary health.
- Protocols that combine these areas can enhance research efficiency.
Purpose of Study
- To develop a rapid protocol for simultaneous assessment of heart and lung functions.
- To provide a learning tool for researchers in the field.
- To facilitate adaptable study designs for varying research scales.
Methods Used
- Microdissection techniques for tissue analysis.
- Physiological assessments of right heart function.
- Evaluation of lung inflammation markers.
- Team-based approach to enhance research collaboration.
Main Results
- The protocol effectively integrates multiple physiological assessments.
- Demonstrated adaptability for both small and large studies.
- Video and figures provide clear guidance on techniques.
- Enhanced understanding of the interplay between heart and lung functions.
Conclusions
- This protocol serves as a valuable resource for researchers.
- It promotes a comprehensive approach to studying cardiovascular and pulmonary interactions.
- Future studies can build upon this framework for deeper insights.
Frequently Asked Questions
What is the main focus of the study?
The study focuses on investigating right heart function, lung inflammation, and the immune response.
How does the protocol benefit researchers?
It provides a rapid and adaptable method for conducting comprehensive studies.
Are there visual aids included in the study?
Yes, the article includes video and figures to illustrate the techniques.
Can this protocol be used for large studies?
Yes, it is designed to be adaptable for both small and large research projects.
What techniques are highlighted in the article?
Microdissection techniques and physiological assessments are key components.
Is this study relevant for immunology research?
Yes, it addresses the immune response in relation to cardiovascular and pulmonary health.
Executive Industry Relevance
This protocol enables integrated assessment of right ventricular function, pulmonary physiology, and immune tissue sampling in murine models, addressing a key challenge in pulmonary hypertension research. By combining hemodynamic measurements with multi-organ tissue harvest, it supports mechanistic de-risking of therapeutic targets linking cardiopulmonary and inflammatory pathways. The approach enhances predictive confidence in preclinical studies by reducing animal use and enabling correlated functional and molecular readouts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses involving heart-lung-immune axis modulation in pulmonary hypertension models.
- Operational Value: Provides direct right ventricular systolic pressure measurements as a functional readout for target engagement and pathway validation.
- Predictive Value: Supports biological de-risking by linking hemodynamic changes with immune and tissue-level responses in disease-relevant systems.
Screening & Assay Development
- Scientific Value: Generates quantitative, reproducible pressure data alongside molecular tissue samples for biomarker discovery and target validation.
- Operational Value: Standardizes tissue harvest workflows to minimize variability and enable high-throughput adaptation for drug screening assays.
- Assay Readiness: Facilitates preparation of validated heart, lung, and immune tissues for downstream analyses such as cytokine profiling or immune cell phenotyping.
Translational & Preclinical Research
- Scientific Value: Offers a disease-relevant system to study networks linking immune, lung, and heart function in inflammatory pulmonary conditions.
- Operational Value: Enables continuity from discovery through preclinical validation by providing correlated physiology and molecular data from the same animal.
- Risk-Adjusted Advancement: Supports go/no-go decisions by integrating functional hemodynamics with mechanistic tissue responses.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to preclinical assessment, enabling efficient data generation for cardiopulmonary-inflammatory disease models.
- Discovery Biology: Supports hypothesis testing and pathway clarification by measuring right ventricular pressure as a surrogate for pulmonary artery pressure in intact, spontaneously breathing mice.
- Screening: Delivers assay-ready tissue samples and quantitative hemodynamic outputs for reliable compound evaluation in pulmonary hypertension research.
- Analytics: Provides direct pressure measurements and harvest of heart, lung, and immune tissues for comparative analysis across experimental conditions.
- Translational Research: Connects functional physiology to molecular changes in lung and immune tissues, supporting biomarker alignment and mechanistic de-risking.
- Enterprise Reuse: Establishes a reusable workflow for integrated cardiopulmonary-immune phenotyping across varied study designs and scales.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity in cardiopulmonary-immune interactions.
- Operational Value: Improves standardization and reproducibility through a structured team-based approach and distinct work-area organization.
- Strategic Value: Increases capital efficiency by reducing animal use and enabling multi-parametric data collection per subject.
- Portfolio Impact: Informs risk-adjusted prioritization by linking functional outcomes with molecular pathway modulation.
Implementation Considerations
- Requires expertise in murine surgical techniques, right heart catheterization, and tissue dissection.
- Dependent on precision instrumentation for pressure measurement and sterile surgical setup.
- Necessitates cross-team standardization between physiology, histology, and immunology workflows.
- Adaptation considerations include model-specific variations in anatomy and disease phenotype.
- Practical limitations include procedural complexity and the need for coordinated team execution to maintain throughput.
Biopharma FAQs
Why does right ventricular systolic pressure measurement matter for target validation?
It provides a direct functional readout of pulmonary artery pressure and right heart afterload, enabling assessment of therapeutic effects on cardiopulmonary hemodynamics in disease models.
How does isolation of the independent variable (e.g., drug or genetic manipulation) fit the discovery pipeline?
By maintaining spontaneous respiration and controlled surgical access, the method isolates cardiovascular responses to interventions, supporting causal inference in target validation studies.
What quantitative dependent variable measurements enable mechanistic de-risking?
Right ventricular systolic pressure serves as a quantitative, real-time hemodynamic readout that correlates with pulmonary vascular resistance and right ventricular function.
Why do replication requirements matter for cross-functional collaboration?
Consistent pressure measurements and standardized tissue harvest ensure reproducibility across physiology, molecular, and immunology teams, enabling integrated data interpretation.
What statistical analysis capabilities are required before implementation?
Teams must be able to correlate continuous pressure measurements with endpoint molecular data from harvested tissues to assess treatment effects and variability.
